HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
CHAMP1
chromosome alignment maintaining phosphoprotein 1
Chromosome 13 Β· 13q34
NCBI Gene: 283489Ensembl: ENSG00000198824.9HGNC: HGNC:20311UniProt: Q96JM3
104PubMed Papers
20Diseases
0Drugs
58Pathogenic Variants
FUNCTIONAL ROLE
Highly Constrained
RESEARCH IMPACT
Variant-Rich
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
nucleuskinetochorecondensed chromosomenuclear bodyintellectual disability, autosomal dominant 40neurodegenerative diseaseIntellectual disabilityblepharophimosis, ptosis, and epicanthus inversus syndrome
✦AI Summary

CHAMP1 (chromosome 13 maintaining phosphoprotein 1) is a multifunctional phosphoprotein with primary roles in both mitotic chromosome 13 and DNA repair. During mitosis, CHAMP1 maintains spindle microtubule attachment to kinetochores and promotes sister chr13 biorientation, essential processes for accurate chromosome 13 1. Beyond its canonical mitotic function, CHAMP1 operates as part of a conserved complex with POGZ and HP1Ξ± that directs heterochromatin assembly at centromeres, telomeres, and other chr13 sites 2. The CHAMP1 complex promotes homology-directed DNA repair (HDR) of double-strand breaks in heterochromatin regions by recruiting the methyltransferase SETDB1 and facilitating H3K9me3 deposition 23. Additionally, CHAMP1 interacts with REV7 to promote homologous recombination repair while reducing non-homologous end joining 4. Recently, a non-canonical role emerged: CHAMP1 acts as a MyoD cofactor to activate Myomaker expression, essential for myoblast fusion and skeletal muscle development 5. Pathologically, CHAMP1 mutations cause neurodevelopmental disorders; loss-of-function variants cause severe intellectual disability and autism through haploinsufficiency 67, while missense variants trigger severe epileptic encephalopathy through probable gain-of-function mechanisms 6. Clinically, CHAMP1 deficiency manifests with developmental delay, hypotonia, muscle weakness, and distinctive dysmorphic features 58.

Sources cited
1
CHAMP1 identified as novel gene causing developmental disorders through large-scale genetic screening
PMID: 25533962
2
CHAMP1 complex promotes heterochromatin assembly and homology-directed DNA repair; defective in CHAMP1 syndrome patient cells
PMID: 39962076
3
Loss-of-function CHAMP1 variants cause severe ID and autism through dominant-negative effect; missense variants cause epileptic encephalopathy through gain-of-function
PMID: 36797464
4
CHAMP1 is essential for human myoblast fusion as MyoD cofactor activating Myomaker expression; mutations cause hypotonia and muscle weakness
PMID: 41540007
5
CHAMP1 complex stabilizes replication forks by facilitating H3K9me3 deposition and shields forks from degradation
PMID: 41481470
6
CHAMP1 mutations associated with intellectual disability and neurodevelopmental disorder with diverse clinical manifestations
PMID: 37628598
7
CHAMP1 premature termination codon mutations cause homologous recombination defect through haploinsufficiency mechanism
PMID: 39738383
8
CHAMP1 binds REV7 and reduces Shieldin complex levels to promote homologous recombination repair
PMID: 36044844
Disease Associationsβ“˜20
intellectual disability, autosomal dominant 40Open Targets
0.73Strong
neurodegenerative diseaseOpen Targets
0.54Moderate
Intellectual disabilityOpen Targets
0.52Moderate
blepharophimosis, ptosis, and epicanthus inversus syndromeOpen Targets
0.52Moderate
genetic disorderOpen Targets
0.52Moderate
Neurodevelopmental disorderOpen Targets
0.44Moderate
complex neurodevelopmental disorderOpen Targets
0.40Weak
retinopathyOpen Targets
0.34Weak
hypertensionOpen Targets
0.26Weak
obesityOpen Targets
0.12Weak
Ichthyosis - hepatosplenomegaly - cerebellar degenerationOpen Targets
0.05Suggestive
ichthyosis-hepatosplenomegaly-cerebellar degeneration syndromeOpen Targets
0.05Suggestive
neoplasmOpen Targets
0.05Suggestive
hereditary angioedemaOpen Targets
0.04Suggestive
hereditary angioedema with normal C1InhOpen Targets
0.04Suggestive
lymphatic malformation 11Open Targets
0.04Suggestive
Increased blood pressureOpen Targets
0.03Suggestive
hemoglobin H diseaseOpen Targets
0.03Suggestive
dominant beta-thalassemiaOpen Targets
0.03Suggestive
glycoprotein storage diseaseOpen Targets
0.03Suggestive
Pathogenic Variants58
NM_032436.4(CHAMP1):c.1192C>T (p.Arg398Ter)Pathogenic
intellectual disability with severe speech impairment|Intellectual disability, autosomal dominant 40|Inborn genetic diseases|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 398
NM_032436.4(CHAMP1):c.1858A>T (p.Lys620Ter)Pathogenic
Intellectual disability|Intellectual disability, autosomal dominant 40
β˜…β˜…β˜†β˜†2022β†’ Residue 620
NM_032436.4(CHAMP1):c.1559_1560del (p.Ser520fs)Pathogenic
Inborn genetic diseases|Intellectual disability
β˜…β˜…β˜†β˜†2021β†’ Residue 520
NM_032436.4(CHAMP1):c.2127T>G (p.Tyr709Ter)Pathogenic
CHAMP1-related syndrome|not provided
β˜…β˜…β˜†β˜†2021β†’ Residue 709
NM_032436.4(CHAMP1):c.2062dup (p.Glu688fs)Likely pathogenic
Intellectual disability, autosomal dominant 40
β˜…β˜†β˜†β˜†2026β†’ Residue 688
NM_032436.4(CHAMP1):c.2081_2082del (p.Ile693_Ser694insTer)Likely pathogenic
Intellectual disability, autosomal dominant 40
β˜…β˜†β˜†β˜†2026β†’ Residue 693
NM_032436.4(CHAMP1):c.292C>T (p.Gln98Ter)Pathogenic
Intellectual disability, autosomal dominant 40
β˜…β˜†β˜†β˜†2026β†’ Residue 98
NM_032436.4(CHAMP1):c.1557_1560del (p.Asp522fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 522
NM_032436.4(CHAMP1):c.1170del (p.Ser389_Trp390insTer)Pathogenic
Inborn genetic diseases
β˜…β˜†β˜†β˜†2024β†’ Residue 389
NM_032436.4(CHAMP1):c.2000_2001del (p.Lys667fs)Pathogenic
Intellectual disability, autosomal dominant 40
β˜…β˜†β˜†β˜†2024β†’ Residue 667
NM_032436.4(CHAMP1):c.2066_2067insCCTT (p.Lys689fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 689
NM_032436.4(CHAMP1):c.2067_2070del (p.Glu690fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2023β†’ Residue 690
NM_032436.4(CHAMP1):c.1903_1906del (p.Glu635fs)Likely pathogenic
Intellectual disability, autosomal dominant 40
β˜…β˜†β˜†β˜†2023β†’ Residue 635
NM_032436.4(CHAMP1):c.2004_2005del (p.Asn669fs)Likely pathogenic
Intellectual disability, autosomal dominant 40
β˜…β˜†β˜†β˜†2023β†’ Residue 669
NM_032436.4(CHAMP1):c.1918_1919del (p.Asp640fs)Pathogenic
See cases
β˜…β˜†β˜†β˜†2022β†’ Residue 640
NM_032436.4(CHAMP1):c.575_576del (p.Pro192fs)Likely pathogenic
Intellectual disability, autosomal dominant 40
β˜…β˜†β˜†β˜†2022β†’ Residue 192
NM_032436.4(CHAMP1):c.824_828del (p.Thr274_Ser275insTer)Likely pathogenic
Intellectual disability, autosomal dominant 40
β˜…β˜†β˜†β˜†2022β†’ Residue 274
NM_032436.4(CHAMP1):c.1741del (p.Glu581fs)Pathogenic
Intellectual disability, autosomal dominant 40
β˜…β˜†β˜†β˜†2022β†’ Residue 581
NM_032436.4(CHAMP1):c.1800_1801insG (p.Leu601fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 601
NM_032436.4(CHAMP1):c.893dup (p.Glu299fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2021β†’ Residue 299
View on ClinVar β†—
Related Genes
CBX3Protein interaction98%RAD50Protein interaction79%MAD2L2Protein interaction73%CBX1Protein interaction73%POGZProtein interaction58%RMDN1Shared pathway25%
Tissue Expression6 tissues
Bone Marrow
100%
Brain
95%
Liver
55%
Heart
46%
Ovary
40%
Lung
39%
Gene Interaction Network
Click a node to explore
CHAMP1CBX3RAD50MAD2L2CBX1POGZRMDN1
PROTEIN STRUCTURE
Preparing viewer…
PDB6EKJ Β· 1.60 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.16Highly Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.07 [0.03–0.16]
RankingsWhere CHAMP1 stands among ~20K protein-coding genes
  • #4,578of 20,598
    Most Researched104 Β· top quartile
  • #1,199of 5,498
    Most Pathogenic Variants58 Β· top quartile
  • #255of 17,882
    Most Constrained (LOEUF)0.16 Β· top 5%
Genes detectedCHAMP1
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Large-scale discovery of novel genetic causes of developmental disorders.
PMID: 25533962
Nature Β· 2015
1.00
2
CHAMP1 complex directs heterochromatin assembly and promotes homology-directed DNA repair.
PMID: 39962076
Nat Commun Β· 2025
0.90
3
CHAMP1-related disorders: pathomechanisms triggered by different genomic alterations define distinct nosological categories.
PMID: 36797464
Eur J Hum Genet Β· 2023
0.80
4
CHAMP1 is an essential regulator for human myoblast fusion and muscle development.
PMID: 41540007
Nat Commun Β· 2026
0.70
5
CHAMP1 complex promotes heterochromatin assembly and reduces replication stress.
PMID: 41481470
Proc Natl Acad Sci U S A Β· 2026
0.60